tiprankstipranks
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Japanese Market
4569
KYORIN Pharmaceutical Co.,Ltd.
RESEARCH TOOLSreports
Want to see JP:4569 full AI Analyst Report?

KYORIN Pharmaceutical Co.,Ltd. (4569) Income Statement

3 Followers

KYORIN Pharmaceutical Co.,Ltd. Income Statement

Last quarter (Q1 2025), KYORIN Pharmaceutical Co.,Ltd.'s total revenue was ¥30.23B, an increase of 6.37% from the same quarter last year. In Q1, KYORIN Pharmaceutical Co.,Ltd.'s net income was ¥2.10B. See KYORIN Pharmaceutical Co.,Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 126.26B¥ 130.09B¥ 119.53B¥ 113.27B¥ 105.53B
Gross Profit
¥ 51.61B¥ 59.51B¥ 51.62B¥ 50.16B¥ 49.44B
Operating Expenses
¥ 48.05B¥ 46.97B¥ 45.39B¥ 45.04B¥ 44.43B
Depreciation and Amortization
¥ 4.66B¥ 4.60B¥ 4.29B¥ 3.84B¥ 3.71B
EBITDA
¥ 8.22B¥ 17.15B¥ 10.52B¥ 8.96B¥ 8.72B
Operating Income
¥ 3.57B¥ 12.55B¥ 6.23B¥ 5.12B¥ 5.00B
Other Income/Expenses
¥ 893.00M¥ 223.00M¥ 1.01B¥ 1.78B¥ 212.00M
Pretax Income
¥ 4.45B¥ 12.77B¥ 7.24B¥ 6.91B¥ 5.22B
Net Income
¥ 3.45B¥ 9.09B¥ 5.47B¥ 4.72B¥ 3.93B
Per Share Metrics
Basic EPS
¥ 60.02¥ 158.16¥ 95.40¥ 82.42¥ 68.62
Diluted EPS
¥ 60.02¥ 158.16¥ 95.40¥ 82.42¥ 68.62
Weighted Average Shares Outstanding
 57.45M 57.45M 57.39M 57.30M 57.30M
Weighted Average Shares Outstanding (Diluted)
 57.45M 57.45M 57.39M 57.30M 57.30M
Currency in JPY

KYORIN Pharmaceutical Co.,Ltd. Earnings and Revenue History